nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0397	0.103	CbGeAlD
Niflumic Acid—Mefenamic acid—AKR1C2—polycystic ovary syndrome	0.0224	0.536	CrCbGaD
Niflumic Acid—SLC16A7—adrenal cortex—polycystic ovary syndrome	0.0161	0.042	CbGeAlD
Niflumic Acid—PLA2G1B—pituitary gland—polycystic ovary syndrome	0.0155	0.0403	CbGeAlD
Niflumic Acid—PLA2G1B—adrenal gland—polycystic ovary syndrome	0.0138	0.036	CbGeAlD
Niflumic Acid—SLC16A7—uterus—polycystic ovary syndrome	0.0133	0.0346	CbGeAlD
Niflumic Acid—SLC16A7—pituitary gland—polycystic ovary syndrome	0.013	0.0339	CbGeAlD
Niflumic Acid—SLC16A7—adipose tissue—polycystic ovary syndrome	0.013	0.0338	CbGeAlD
Niflumic Acid—PLA2G1B—female gonad—polycystic ovary syndrome	0.0129	0.0336	CbGeAlD
Niflumic Acid—Mefenamic acid—AKR1C1—polycystic ovary syndrome	0.0123	0.294	CrCbGaD
Niflumic Acid—PLA2G1B—endocrine gland—polycystic ovary syndrome	0.012	0.0312	CbGeAlD
Niflumic Acid—PLA2G4A—adrenal cortex—polycystic ovary syndrome	0.0117	0.0304	CbGeAlD
Niflumic Acid—SLC16A7—adrenal gland—polycystic ovary syndrome	0.0116	0.0303	CbGeAlD
Niflumic Acid—UGT1A9—endocrine gland—polycystic ovary syndrome	0.011	0.0286	CbGeAlD
Niflumic Acid—SLC16A7—vagina—polycystic ovary syndrome	0.0108	0.0281	CbGeAlD
Niflumic Acid—PLA2G4A—endometrium—polycystic ovary syndrome	0.0104	0.0271	CbGeAlD
Niflumic Acid—SLC16A7—endocrine gland—polycystic ovary syndrome	0.0101	0.0263	CbGeAlD
Niflumic Acid—PLA2G4A—pituitary gland—polycystic ovary syndrome	0.00943	0.0245	CbGeAlD
Niflumic Acid—PLA2G4A—adipose tissue—polycystic ovary syndrome	0.00939	0.0244	CbGeAlD
Niflumic Acid—SLC16A1—endometrium—polycystic ovary syndrome	0.00917	0.0239	CbGeAlD
Niflumic Acid—SLC16A1—uterus—polycystic ovary syndrome	0.00845	0.022	CbGeAlD
Niflumic Acid—PLA2G4A—adrenal gland—polycystic ovary syndrome	0.00842	0.0219	CbGeAlD
Niflumic Acid—SLC16A1—pituitary gland—polycystic ovary syndrome	0.0083	0.0216	CbGeAlD
Niflumic Acid—SLC16A1—adipose tissue—polycystic ovary syndrome	0.00827	0.0215	CbGeAlD
Niflumic Acid—PLA2G4A—female gonad—polycystic ovary syndrome	0.00785	0.0204	CbGeAlD
Niflumic Acid—PLA2G4A—vagina—polycystic ovary syndrome	0.0078	0.0203	CbGeAlD
Niflumic Acid—SLC16A1—adrenal gland—polycystic ovary syndrome	0.00741	0.0193	CbGeAlD
Niflumic Acid—PLA2G4A—endocrine gland—polycystic ovary syndrome	0.0073	0.019	CbGeAlD
Niflumic Acid—Mefenamic acid—AKR1C3—polycystic ovary syndrome	0.00714	0.171	CrCbGaD
Niflumic Acid—SLC16A1—female gonad—polycystic ovary syndrome	0.00691	0.018	CbGeAlD
Niflumic Acid—SLC16A1—endocrine gland—polycystic ovary syndrome	0.00643	0.0167	CbGeAlD
Niflumic Acid—PTGS2—embryo—polycystic ovary syndrome	0.00537	0.014	CbGeAlD
Niflumic Acid—PTGS2—adrenal cortex—polycystic ovary syndrome	0.0044	0.0115	CbGeAlD
Niflumic Acid—PTGS1—endometrium—polycystic ovary syndrome	0.00411	0.0107	CbGeAlD
Niflumic Acid—PTGS2—endometrium—polycystic ovary syndrome	0.00393	0.0102	CbGeAlD
Niflumic Acid—PTGS1—uterus—polycystic ovary syndrome	0.00379	0.00987	CbGeAlD
Niflumic Acid—PTGS1—pituitary gland—polycystic ovary syndrome	0.00372	0.00969	CbGeAlD
Niflumic Acid—PTGS1—adipose tissue—polycystic ovary syndrome	0.00371	0.00965	CbGeAlD
Niflumic Acid—PTGS2—uterus—polycystic ovary syndrome	0.00362	0.00943	CbGeAlD
Niflumic Acid—PTGS2—pituitary gland—polycystic ovary syndrome	0.00356	0.00926	CbGeAlD
Niflumic Acid—PTGS2—adipose tissue—polycystic ovary syndrome	0.00354	0.00923	CbGeAlD
Niflumic Acid—PTGS1—adrenal gland—polycystic ovary syndrome	0.00333	0.00866	CbGeAlD
Niflumic Acid—PTGS2—adrenal gland—polycystic ovary syndrome	0.00318	0.00828	CbGeAlD
Niflumic Acid—PTGS1—female gonad—polycystic ovary syndrome	0.0031	0.00807	CbGeAlD
Niflumic Acid—PTGS1—vagina—polycystic ovary syndrome	0.00308	0.00802	CbGeAlD
Niflumic Acid—PTGS2—female gonad—polycystic ovary syndrome	0.00296	0.00772	CbGeAlD
Niflumic Acid—PTGS2—vagina—polycystic ovary syndrome	0.00295	0.00767	CbGeAlD
Niflumic Acid—PTGS1—endocrine gland—polycystic ovary syndrome	0.00288	0.00751	CbGeAlD
Niflumic Acid—PTGS2—endocrine gland—polycystic ovary syndrome	0.00276	0.00718	CbGeAlD
Niflumic Acid—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000299	0.000521	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000298	0.000519	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—GNAS—polycystic ovary syndrome	0.000296	0.000516	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CYP19A1—polycystic ovary syndrome	0.000296	0.000515	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000292	0.000509	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000291	0.000507	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000288	0.000502	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000285	0.000497	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000282	0.000492	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PNPLA2—polycystic ovary syndrome	0.00028	0.000488	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000279	0.000486	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000277	0.000483	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000275	0.000479	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000273	0.000476	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.000273	0.000476	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000273	0.000476	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.000272	0.000474	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000272	0.000474	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—HMMR—polycystic ovary syndrome	0.000272	0.000474	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00027	0.00047	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000268	0.000466	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000265	0.000462	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000265	0.000462	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GNAS—polycystic ovary syndrome	0.000264	0.00046	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000262	0.000456	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—HSD3B1—polycystic ovary syndrome	0.00026	0.000453	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000258	0.000449	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—RRM2—polycystic ovary syndrome	0.000257	0.000448	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000257	0.000447	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000254	0.000443	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—STAR—polycystic ovary syndrome	0.000253	0.000441	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—NCOR1—polycystic ovary syndrome	0.000251	0.000438	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00025	0.000436	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00025	0.000435	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000248	0.000433	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—YAP1—polycystic ovary syndrome	0.000248	0.000432	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IGF1—polycystic ovary syndrome	0.000247	0.00043	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—AKT2—polycystic ovary syndrome	0.000246	0.000429	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000243	0.000424	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000243	0.000423	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CYP1A1—polycystic ovary syndrome	0.000238	0.000415	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NAMPT—polycystic ovary syndrome	0.000238	0.000415	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000237	0.000413	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—LHB—polycystic ovary syndrome	0.000237	0.000413	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000235	0.000409	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000234	0.000408	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000232	0.000404	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—HSD3B2—polycystic ovary syndrome	0.000232	0.000403	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000228	0.000398	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000228	0.000397	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—HMMR—polycystic ovary syndrome	0.000226	0.000393	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AKR1C1—polycystic ovary syndrome	0.000224	0.000391	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000224	0.000391	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—MTHFR—polycystic ovary syndrome	0.000222	0.000387	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000222	0.000387	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000221	0.000386	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00022	0.000383	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000219	0.000381	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000216	0.000377	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000216	0.000377	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000216	0.000377	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000215	0.000375	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000214	0.000373	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000213	0.000371	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000208	0.000363	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000208	0.000362	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.000206	0.000359	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—SULT2A1—polycystic ovary syndrome	0.000206	0.000359	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000205	0.000356	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000204	0.000355	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FST—polycystic ovary syndrome	0.000203	0.000354	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000202	0.000351	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.0002	0.000349	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—RRM2—polycystic ovary syndrome	0.0002	0.000348	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000198	0.000345	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—LHB—polycystic ovary syndrome	0.000196	0.000342	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000196	0.000341	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000194	0.000337	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—YAP1—polycystic ovary syndrome	0.000193	0.000336	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000192	0.000334	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IGF1—polycystic ovary syndrome	0.000192	0.000334	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—AKT2—polycystic ovary syndrome	0.000192	0.000334	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—TH—polycystic ovary syndrome	0.000189	0.000329	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000188	0.000328	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000188	0.000327	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000186	0.000324	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000186	0.000323	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NAMPT—polycystic ovary syndrome	0.000185	0.000322	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000184	0.000321	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.000184	0.00032	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000184	0.00032	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.000184	0.00032	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000183	0.000319	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP11A1—polycystic ovary syndrome	0.000183	0.000318	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000182	0.000317	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000181	0.000316	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000181	0.000316	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PPARG—polycystic ovary syndrome	0.00018	0.000314	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—POMC—polycystic ovary syndrome	0.000178	0.000309	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000177	0.000308	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—INS—polycystic ovary syndrome	0.000177	0.000308	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000175	0.000306	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000174	0.000304	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000174	0.000303	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000173	0.000302	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000173	0.000301	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AKR1C3—polycystic ovary syndrome	0.000173	0.000301	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000173	0.000301	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000172	0.000299	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000171	0.000298	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP17A1—polycystic ovary syndrome	0.00017	0.000296	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00017	0.000296	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—RRM2—polycystic ovary syndrome	0.000166	0.000288	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000164	0.000286	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000164	0.000285	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000162	0.000282	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000161	0.000281	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—VEGFA—polycystic ovary syndrome	0.000161	0.000281	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.00016	0.000279	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—YAP1—polycystic ovary syndrome	0.00016	0.000278	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000159	0.000277	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000156	0.000272	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GNAS—polycystic ovary syndrome	0.000154	0.000269	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NAMPT—polycystic ovary syndrome	0.000153	0.000267	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000152	0.000266	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000152	0.000265	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000151	0.000264	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000151	0.000264	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.00015	0.000262	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000149	0.000259	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—TH—polycystic ovary syndrome	0.000147	0.000256	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NCOR1—polycystic ovary syndrome	0.000147	0.000256	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000146	0.000255	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000146	0.000254	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000144	0.000251	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.000144	0.00025	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000143	0.000249	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—SLC2A4—polycystic ovary syndrome	0.000143	0.000249	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000142	0.000248	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000141	0.000245	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000141	0.000245	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000139	0.000243	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000139	0.000243	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000139	0.000243	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000138	0.00024	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000135	0.000235	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP19A1—polycystic ovary syndrome	0.000134	0.000234	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.000133	0.000232	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.000132	0.00023	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000131	0.000228	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000131	0.000228	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000131	0.000227	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.00013	0.000227	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MTHFR—polycystic ovary syndrome	0.00013	0.000226	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000127	0.000221	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—VEGFA—polycystic ovary syndrome	0.000125	0.000218	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000125	0.000218	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000125	0.000217	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000124	0.000217	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000124	0.000216	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000123	0.000215	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000123	0.000214	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TH—polycystic ovary syndrome	0.000122	0.000212	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.000122	0.000212	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000122	0.000212	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.00012	0.000209	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GNAS—polycystic ovary syndrome	0.00012	0.000209	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000119	0.000206	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NAMPT—polycystic ovary syndrome	0.000119	0.000206	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000117	0.000203	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000115	0.000201	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000115	0.0002	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000114	0.000199	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NCOR1—polycystic ovary syndrome	0.000114	0.000199	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000114	0.000199	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000111	0.000194	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000111	0.000193	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	0.000111	0.000193	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00011	0.000192	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	0.000109	0.00019	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP1A1—polycystic ovary syndrome	0.000108	0.000189	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000108	0.000189	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	0.000107	0.000187	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PPARG—polycystic ovary syndrome	0.000105	0.000184	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—POMC—polycystic ovary syndrome	0.000104	0.000181	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—INS—polycystic ovary syndrome	0.000103	0.00018	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	0.000103	0.00018	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MTHFR—polycystic ovary syndrome	0.000101	0.000176	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.0001	0.000175	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GNAS—polycystic ovary syndrome	9.95e-05	0.000173	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TH—polycystic ovary syndrome	9.93e-05	0.000173	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	9.93e-05	0.000173	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.87e-05	0.000172	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	9.8e-05	0.000171	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.73e-05	0.00017	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	9.66e-05	0.000168	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.56e-05	0.000167	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NCOR1—polycystic ovary syndrome	9.48e-05	0.000165	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NRG1—polycystic ovary syndrome	9.39e-05	0.000163	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	9.32e-05	0.000162	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	9.26e-05	0.000161	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	9.16e-05	0.00016	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	9.11e-05	0.000159	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	9.08e-05	0.000158	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP1A1—polycystic ovary syndrome	8.98e-05	0.000156	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PRL—polycystic ovary syndrome	8.74e-05	0.000152	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MTHFR—polycystic ovary syndrome	8.37e-05	0.000146	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PPARG—polycystic ovary syndrome	8.2e-05	0.000143	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	8.11e-05	0.000141	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—POMC—polycystic ovary syndrome	8.08e-05	0.000141	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IRS2—polycystic ovary syndrome	8.04e-05	0.00014	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—INS—polycystic ovary syndrome	8.04e-05	0.00014	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TH—polycystic ovary syndrome	7.89e-05	0.000137	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LEP—polycystic ovary syndrome	7.87e-05	0.000137	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	7.72e-05	0.000135	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	7.67e-05	0.000134	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	7.32e-05	0.000128	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NCOR1—polycystic ovary syndrome	7.32e-05	0.000128	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	7.21e-05	0.000126	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NRG1—polycystic ovary syndrome	7.19e-05	0.000125	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IRS1—polycystic ovary syndrome	7.02e-05	0.000122	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	6.83e-05	0.000119	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPARG—polycystic ovary syndrome	6.79e-05	0.000118	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—POMC—polycystic ovary syndrome	6.76e-05	0.000118	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—INS—polycystic ovary syndrome	6.72e-05	0.000117	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—POMC—polycystic ovary syndrome	6.7e-05	0.000117	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—INS—polycystic ovary syndrome	6.66e-05	0.000116	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.5e-05	0.000113	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.5e-05	0.000113	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTHFR—polycystic ovary syndrome	6.47e-05	0.000113	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	6.44e-05	0.000112	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.17e-05	0.000108	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IRS2—polycystic ovary syndrome	6.16e-05	0.000107	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	6.13e-05	0.000107	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	5.81e-05	0.000101	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	5.54e-05	9.64e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—POMC—polycystic ovary syndrome	5.46e-05	9.51e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—INS—polycystic ovary syndrome	5.43e-05	9.46e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	5.42e-05	9.44e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IRS1—polycystic ovary syndrome	5.37e-05	9.36e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—INS—polycystic ovary syndrome	5.15e-05	8.97e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKT2—polycystic ovary syndrome	4.97e-05	8.67e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.97e-05	8.66e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	4.73e-05	8.23e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	4.39e-05	7.66e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—POMC—polycystic ovary syndrome	4.33e-05	7.55e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—INS—polycystic ovary syndrome	4.31e-05	7.51e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.25e-05	7.4e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6—polycystic ovary syndrome	2.94e-05	5.12e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6—polycystic ovary syndrome	2.25e-05	3.92e-05	CbGpPWpGaD
